$5.18
0.39% yesterday
Nasdaq, Sep 27, 09:48 pm CET
ISIN
US53216B1044
Symbol
LFMD

LifeMD Stock price

$5.21
+0.30 6.11% 1M
-4.97 48.82% 6M
-3.08 37.15% YTD
-0.29 5.27% 1Y
-1.63 23.83% 3Y
-1.39 21.06% 5Y
-1.39 21.06% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.01 0.19%
ISIN
US53216B1044
Symbol
LFMD
Industry

Key metrics

Market capitalization $223.96m
Enterprise Value $211.23m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 13.57
EV/Sales (TTM) EV/Sales 1.18
P/S ratio (TTM) P/S ratio 1.26
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 38.63%
Revenue (TTM) Revenue $178.28m
EBIT (operating result TTM) EBIT $-19.22m
Free Cash Flow (TTM) Free Cash Flow $15.57m
Cash position $35.70m
EPS (TTM) EPS $-0.70
P/E forward negative
P/S forward 1.09
EV/Sales forward 1.03
Short interest 13.91%
Show more

Is LifeMD a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

LifeMD Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a LifeMD forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a LifeMD forecast:

Buy
100%

Financial data from LifeMD

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
178 178
39% 39%
100%
- Direct Costs 29 29
18% 18%
16%
150 150
43% 43%
84%
- Selling and Administrative Expenses 153 153
32% 32%
86%
- Research and Development Expense 7.99 7.99
81% 81%
4%
-11 -11
31% 31%
-6%
- Depreciation and Amortization 8.06 8.06
52% 52%
5%
EBIT (Operating Income) EBIT -19 -19
10% 10%
-11%
Net Profit -24 -24
22% 22%
-13%

In millions USD.

Don't miss a Thing! We will send you all news about LifeMD directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeMD Stock News

Neutral
GlobeNewsWire
3 days ago
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
Positive
Seeking Alpha
17 days ago
LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth and GLP1 offerings show significant potential, with the stock priced at 14x forward EBITDA. I have revised my price target from $20 to $15 per share by summer 2025, due to management's credibility issu...
Neutral
GlobeNewsWire
about one month ago
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September:
More LifeMD News

Company Profile

LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.

Head office United States
CEO Justin Schreiber
Employees 232
Founded 1987
Website www.lifemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today